latanoprost and Central-Serous-Chorioretinopathy

To report a case of central serous chorioretinopathy (CSC) as a possible complication of latanoprost treatment.. A 65-year-old woman presented with a 1-week history of blurred vision and metamorphopsia in her right eye. She was previously diagnosed with unilateral glaucoma, and treatment was initiated with topical latanoprost 0.005% for the right eye. The symptoms occurred 1 month after initiation of glaucoma treatment.. Visual acuity (VA) of the patient had reduced to 20/50 in right eye. Fluorescein angiography revealed a focal RPE leak near to the fovea with neurosensory detachment due to CSC, which was confirmed by optical coherence tomography. After cessation of the therapy, her clinical and morphological status improved spontaneously. The neurosensory detachment resolved almost completely and VA improved to 20/20 simultaneously.. The authors report the first case of CSC associated with latonoprost therapy. This case demonstrates that topical latanoprost may lead to the development of CSC.

Topics: Aged; Antihypertensive Agents; Central Serous Chorioretinopathy; Female; Fluorescein Angiography; Glaucoma; Humans; Latanoprost; Prostaglandins F, Synthetic; Remission, Spontaneous; Retinal Detachment; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity